<code id='8E2994BB75'></code><style id='8E2994BB75'></style>
    • <acronym id='8E2994BB75'></acronym>
      <center id='8E2994BB75'><center id='8E2994BB75'><tfoot id='8E2994BB75'></tfoot></center><abbr id='8E2994BB75'><dir id='8E2994BB75'><tfoot id='8E2994BB75'></tfoot><noframes id='8E2994BB75'>

    • <optgroup id='8E2994BB75'><strike id='8E2994BB75'><sup id='8E2994BB75'></sup></strike><code id='8E2994BB75'></code></optgroup>
        1. <b id='8E2994BB75'><label id='8E2994BB75'><select id='8E2994BB75'><dt id='8E2994BB75'><span id='8E2994BB75'></span></dt></select></label></b><u id='8E2994BB75'></u>
          <i id='8E2994BB75'><strike id='8E2994BB75'><tt id='8E2994BB75'><pre id='8E2994BB75'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:65
          Photo illustration based on photograph of The University of Texas MD Anderson Cancer Center in Houston, Texas in 2022
          Photo illustration: STAT; Photo: Adobe

          Prominent immunologist and oncologist Padmanee Sharma defended herself in court on Friday against a lawsuit that alleges she threatened to undermine a junior faculty member’s career, made defamatory comments about the younger scientist, and attempted to take credit for work that she didn’t do.

          In legal filings submitted to the Harris County District Court, Sharma said that she made substantial contributions to an immunotherapy project that were ignored, and that a third-party assessment commissioned by MD Anderson Cancer Center concluded Sharma should be given credit for her role. Sharma had previously issued a general denial of the allegations against her and claimed immunity from the suit as a government employee. As part of the University of Texas, MD Anderson is a state institution.

          advertisement

          The filing, which was submitted by Texas Attorney General Ken Paxton and lawyers in his office, also argued that the junior researcher’s lawsuit should be made against MD Anderson, not Sharma, and asked the court to dismiss the suit if it is not amended within 30 days. “Dr. Sharma is not a proper party to this lawsuit; only MDACC is,” the filing states. “This lawsuit is about proper accreditation in scientific literature for research performed at MDACC by MDACC faculty.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          New definition of a human embryo proposed amid rapid advances
          New definition of a human embryo proposed amid rapid advances

          ChristopherFurlong/GettyImagesWhensomeonesaysthewordembryo,whatdoyouthinkof?Probablythatpictureyou’v

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          The EU Joint Clinical Assessment needs to live up to its promise

          RonaldWittek,PoolPhotoviaAPToday,thecriteriausedtoassesstheclinicalvalueofnewpharmaceuticalsandmedic